EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Substance use and psychiatric outcomes following substance use disorder treatment: An 18‐month prospective cohort study in Chile

Ignacio Bórquez iD, Noa Krawczyk iD, Ellicott C Matthay iD, Rafael Charris, Sofía Dupré, Mariel Mateo iD, Pablo Carvacho, Magdalena Cerdá iD, Álvaro Castillo-Carniglia iD, Eduardo Valenzuela

Addiction · 2025

DOI: 10.1111/add.16731 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Addiction, 2025. Verfasst von Ignacio Bórquez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Opioid Epidemiology and Policy (COEP), Division of Epidemiology, Department of Population Health, New York University Grossman School of M…. Hauptthemen laut MEDLINE: Substance-Related Disorders, Mental Disorders, Patient Compliance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, Agencia Nacional de Investigación y Desarrollo, Dirección de Presupuestos, Ministerio de Hacienda, Chile.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims Evidence from high‐income countries has linked duration and compliance with treatment for substance use disorders (SUDs) with reductions in substance use and improvements in mental health. Generalizing these findings to other regions like South America, where opioid and injection drug use is uncommon, is not straightforward. We examined if length of time in treatment and compliance with treatment reduced subsequent substance use and presence of psychiatric comorbidities.

Design

Prospective cohort analysis (3 assessments, 18 months) using inverse probability weighting to account for confounding and loss to follow‐up. Settings Outpatient/inpatient programs in Región Metropolitana, Chile.

Participants

Individuals initiating publicly funded treatment ( n = 399).

Measurements

Exposures included length of time in (0–3, 4–7, 8 + months, currently in) and compliance with treatment (not completed, completed, currently in) measured in the intermediate assessment (12 months). Primary outcomes were past‐month use of primary substance (most problematic) and current psychiatric comorbidities (major depressive episode, panic, anxiety or post‐traumatic stress disorders) measured 6 months later (18 months). Secondary outcomes included past month use of alcohol, cannabis, cocaine powder and cocaine paste.

Findings

18.3% [95% confidence interval (CI) = 14.7%–22.6%] of individuals participated for 3 or fewer months in treatment and 50.1% (95% CI = 45.2%–55.1%) did not complete their treatment plan at 12 months. Participating for 8 + months in treatment was associated with lower risk of past month use of primary substance at 18 months [vs. 0–3 months, risk ratio (RR) = 0.62, 95% CI = 0.38–1.00] and completion of treatment (vs. not completed, RR = 0.49, 95% CI = 0.30–0.80). Neither participating 8 + months (vs. 0–3 months, RR = 0.83, 95% CI = 0.57–1.22) nor treatment completion (vs. not completed, RR = 1.02, 95% CI = 0.72–1.46) were associated with lower risk of psychiatric comorbidity at 18 months.

Conclusions

Longer time in treatment and compliance with treatment for substance use disorders in Chile appears to be associated with lower risk of substance use but not current comorbid psychiatric conditions 18 months after treatment initiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersMental DisordersPatient ComplianceHumansChileMaleFemaleProspective StudiesAdultMiddle AgedComorbidityTime FactorsTreatment OutcomeYoung AdultMajor Depressive DisorderStress Disorders, Post-Traumatic

Stichwörter der Autor:innen

South Americaalcoholcocaineinverse probability weightingsubstance use disordertreatment outcomes

Autor:innen und Institutionen

  • Center for Opioid Epidemiology and Policy (COEP), Division of Epidemiology, Department of Population Health, New York University Grossman School of Medicine, New York, NY, USA.
  • Millennium Nucleus for the Evaluation and Analysis of Drug Policies (nDP), Chile.
  • Center for Studies on Justice and Society (CJS), Pontificia Universidad Católica de, Chile.
  • School of Criminology and Criminal Justice, Griffith University, Australia.
  • Departamento Nacional de Salud Pública, Facultad de Medicina y Ciencia, Universidad San Sebastián, Chile.

ORCID-Profile: Ignacio Bórquez, Noa Krawczyk, Ellicott C Matthay, Mariel Mateo, Magdalena Cerdá, Álvaro Castillo-Carniglia

Förderung

  • NIDA NIH HHS
  • Agencia Nacional de Investigación y Desarrollo
  • Dirección de Presupuestos, Ministerio de Hacienda, Chile

Zitieren

APA

Bórquez, I., Krawczyk, N., Matthay, E. C., Charris, R., Dupré, S., Mateo, M., Carvacho, P., Cerdá, M., Castillo-Carniglia, Á., & Valenzuela, E. (2025). Substance use and psychiatric outcomes following substance use disorder treatment: An 18‐month prospective cohort study in Chile. Addiction. https://doi.org/10.1111/add.16731

Vancouver

Bórquez I, Krawczyk N, Matthay EC, Charris R, Dupré S, Mateo M, et al. Substance use and psychiatric outcomes following substance use disorder treatment: An 18‐month prospective cohort study in Chile. Addiction. 2025. doi:10.1111/add.16731

BibTeX
@article{Brquez2025,
  author = {Bórquez, Ignacio and Krawczyk, Noa and Matthay, Ellicott C and Charris, Rafael and Dupré, Sofía and Mateo, Mariel and Carvacho, Pablo and Cerdá, Magdalena and Castillo-Carniglia, Álvaro and Valenzuela, Eduardo},
  title = {Substance use and psychiatric outcomes following substance use disorder treatment: An 18‐month prospective cohort study in Chile},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.16731}
}
Kostenlos starten →